ID | 112935 |
Title Alternative | The role of Pim-2 in myeloma bone destruction
|
Author |
Teramachi, Jumpei
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Hiasa, Masahiro
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Oda, Asuka
Tokushima University
Nakamura, Shingen
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Amachi, Ryota
Tokushima University
Iwasa, Masami
Tokushima University
Fujii, Shiroh
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Miki, Hirokazu
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Yoshida, Sumiko
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Endo, Itsuro
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Haneji, Tatsuji
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Matsumoto, Toshio
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Abe, Masahiro
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
|
Keywords | myeloma
Pim‐2
receptor activator of NF‐κB ligand
osteoclastogenesis
bone destruction
|
Content Type |
Journal Article
|
Journal Title |
British Journal of Haematology
|
ISSN | 13652141
00071048
|
NCID | AA11618011
AA00574570
|
Publisher | John Wiley & Sons Ltd
|
Volume | 180
|
Issue | 4
|
Start Page | 581
|
End Page | 585
|
Published Date | 2016-10-17
|
Remark | This is the peer reviewed version of the following article: Teramachi, J. , Hiasa, M. , Oda, A. , Harada, T. , Nakamura, S. , Amachi, R. , Tenshin, H. , Iwasa, M. , Fujii, S. , Kagawa, K. , Miki, H. , Kurahashi, K. , Yoshida, S. , Endo, I. , Haneji, T. , Matsumoto, T. and Abe, M. (2018), Pim‐2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma. Br J Haematol, 180: 581-585, which has been published in final form at https://doi.org/10.1111/bjh.14388. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
|
EDB ID | |
DOI (Published Version) | |
URL ( Publisher's Version ) | |
FullText File | |
language |
eng
|
TextVersion |
Author
|
departments |
Oral Sciences
University Hospital
Medical Sciences
Institute of Advanced Medical Sciences
|